Bill Text: IL HB1191 | 2011-2012 | 97th General Assembly | Amended

NOTE: There are more recent revisions of this legislation. Read Latest Draft

---

Bill Title: Amends the State Employees Group Insurance Act of 1971, Counties Code, Illinois Municipal Code, School Code, Illinois Insurance Code, Health Maintenance Organization Act, and Voluntary Health Services Plans Act. Sets forth definitions for "qualified individual" and "life-threatening condition". Sets forth provisions concerning coverage for routine patient care with regard to denial, limits, additional conditions, and discrimination concerning approved clinical trials according to the trial protocol with respect to the treatment of cancer or other life-threatening diseases or conditions. Amends the Illinois Public Aid Code in the provision concerning medical services to provide that the Department of Healthcare and Family Services shall ensure that cancer patients in need of dental treatment prior to the administration of chemotherapy have access to such dental services and shall develop a mechanism whereby mammography providers may download a standing order via the Internet for screening mammography for certain women eligible for mammography coverage. Amends the Radiation Protection Act of 1990 in the provision concerning limitations on application of radiation to human beings and requirements for radiation installation operators providing mammography services. Provides that each facility that performs mammograms shall upon request by or on behalf of the patient transfer the original mammograms and copies of the reports without charge to the patient. Makes other changes.

Spectrum: Partisan Bill (Democrat 26-1)

Status: (Passed) 2011-07-11 - Public Act . . . . . . . . . 97-0091 [HB1191 Detail]

Download: Illinois-2011-HB1191-Amended.html

---

Rep. Greg Harris

Filed: 3/14/2011

09700HB1191ham003 LRB097 06572 ASK 53006 a
AMENDMENT TO HOUSE BILL 1191
AMENDMENT NO. ______. Amend House Bill 1191 by replacing
everything after the enacting clause with the following:
"Section 5. The Illinois Insurance Code is amended by
changing Section 364.01 as follows:
(215 ILCS 5/364.01)
Sec. 364.01. Qualified clinical cancer trials.
(a) No individual or group policy of accident and health
insurance issued or renewed in this State may be cancelled or
non-renewed for any individual based on that individual's
participation in a qualified clinical cancer trial.
(b) Qualified clinical cancer trials must meet the
following criteria:
(1) the effectiveness of the treatment has not been
determined relative to established therapies;
(2) the trial is under clinical investigation as part

09700HB1191ham003 - 2 - LRB097 06572 ASK 53006 a
of an approved cancer research trial in Phase II, Phase
III, or Phase IV of investigation;
(3) the trial is:
(A) approved by the Food and Drug Administration;
or
(B) approved and funded by the National Institutes
of Health, the Centers for Disease Control and
Prevention, the Agency for Healthcare Research and
Quality, the United States Department of Defense, the
United States Department of Veterans Affairs, or the
United States Department of Energy in the form of an
investigational new drug application, or a cooperative
group or center of any entity described in this
subdivision (B); and
(4) the patient's primary care physician, if any, is
involved in the coordination of care.
(c) No group policy of accident and health insurance shall
exclude coverage for any routine patient care administered to
an insured who is a qualified individual participating in a
qualified clinical cancer trial, if the policy covers that same
routine patient care of insureds not enrolled in a qualified
clinical cancer trial.
(d) The coverage that may not be excluded under subsection
(c) of this Section is subject to all terms, conditions,
restrictions, exclusions, and limitations that apply to the
same routine patient care received by an insured not enrolled

09700HB1191ham003 - 3 - LRB097 06572 ASK 53006 a
in a qualified clinical cancer trial, including the application
of any authorization requirement, utilization review, or
medical management practices. The insured or enrollee shall
incur no greater out-of-pocket liability than had the insured
or enrollee not enrolled in a qualified clinical cancer trial.
(e) If the group policy of accident and health insurance
uses a preferred provider program and a preferred provider
provides routine patient care in connection with a qualified
clinical cancer trial, then the insurer may require the insured
to use the preferred provider if the preferred provider agrees
to provide to the insured that routine patient care.
(f) A qualified clinical cancer trial may not pay or refuse
to pay for routine patient care of a individual participating
in the trial, based in whole or in part on the person's having
or not having coverage for routine patient care under a group
policy of accident and health insurance.
(g) Nothing in this Section shall be construed to limit an
insurer's coverage with respect to clinical trials.
(h) Nothing in this Section shall require coverage for
out-of-network services where the underlying health benefit
plan does not provide coverage for out-of-network services.
(i) As used in this Section, "routine patient care" means
all health care services provided in the qualified clinical
cancer trial that are otherwise generally covered under the
policy if those items or services were not provided in
connection with a qualified clinical cancer trial consistent

09700HB1191ham003 - 4 - LRB097 06572 ASK 53006 a
with the standard of care for the treatment of cancer,
including the type and frequency of any diagnostic modality,
that a provider typically provides to a cancer patient who is
not enrolled in a qualified clinical cancer trial. "Routine
patient care" does not include, and a group policy of accident
and health insurance may exclude, coverage for:
(1) a health care service, item, or drug that is the
subject of the cancer clinical trial;
(2) a health care service, item, or drug provided
solely to satisfy data collection and analysis needs for
the qualified clinical cancer trial that is not used in the
direct clinical management of the patient;
(3) an investigational drug or device that has not been
approved for market by the United States Food and Drug
Administration;
(4) transportation, lodging, food, or other expenses
for the patient or a family member or companion of the
patient that are associated with the travel to or from a
facility providing the qualified clinical cancer trial,
unless the policy covers these expenses for a cancer
patient who is not enrolled in a qualified clinical cancer
trial;
(5) a health care service, item, or drug customarily
provided by the qualified clinical cancer trial sponsors
free of charge for any patient;
(6) a health care service or item, which except for the

09700HB1191ham003 - 5 - LRB097 06572 ASK 53006 a
fact that it is being provided in a qualified clinical
cancer trial, is otherwise specifically excluded from
coverage under the insured's policy, including:
(A) costs of extra treatments, services,
procedures, tests, or drugs that would not be performed
or administered except for the fact that the insured is
participating in the cancer clinical trial; and
(B) costs of nonhealth care services that the
patient is required to receive as a result of
participation in the approved cancer clinical trial;
(7) costs for services, items, or drugs that are
eligible for reimbursement from a source other than a
patient's contract or policy providing for third-party
payment or prepayment of health or medical expenses,
including the sponsor of the approved cancer clinical
trial; or
(8) costs associated with approved cancer clinical
trials designed exclusively to test toxicity or disease
pathophysiology, unless the policy covers these expenses
for a cancer patient who is not enrolled in a qualified
clinical cancer trial; or
(9) a health care service or item that is eligible for
reimbursement by a source other than the insured's policy,
including the sponsor of the qualified clinical cancer
trial.
The definitions of the terms "health care services",

09700HB1191ham003 - 6 - LRB097 06572 ASK 53006 a
"Non-Preferred Provider", "Preferred Provider", and "Preferred
Provider Program", stated in 50 IL Adm. Code Part 2051
Preferred Provider Programs apply to these terms in this
Section.
(j) The external review procedures established under the
Health Carrier External Review Act shall apply to the
provisions under this Section.
(Source: P.A. 93-1000, eff. 1-1-05.)
Section 99. Effective date. This Act takes effect January
1, 2012.".